论文部分内容阅读
目的探讨脑心通胶囊联合阿托伐他汀治疗脑梗死患者的临床疗效。方法选择2011年4月-2012年4月于我院就诊的80例脑梗死患者,随机分为实验组和对照组各40例,对照组采用阿托伐他汀治疗,实验组在对照组基础上加用脑心通胶囊。结果两组患者均取得了显著疗效,实验组总有效率92.5%,高于对照组的72.5%,差异显著(P<0.05)。两组治疗前血脂相比无明显差异(P>0.05),实验组治疗后血脂改善程度大于对照组,差异显著(P<0.05)。结论脑心通胶囊联合阿托伐他汀治疗脑梗死患者疗效更好,改善患者血脂水平,适合临床长期推广应用。
Objective To investigate the clinical effect of Naoxintong capsule combined with atorvastatin on patients with cerebral infarction. Methods Eighty cerebral infarction patients treated in our hospital from April 2011 to April 2012 were randomly divided into experimental group (40 cases) and control group (40 cases). Atorvastatin group was used as the control group. On the basis of the control group Add brain brain capsule. Results The two groups of patients achieved a significant effect, the total effective rate was 92.5% in the experimental group, which was significantly higher than that in the control group (72.5%, P <0.05). There was no significant difference in serum lipids between the two groups before treatment (P> 0.05). The improvement of blood lipids in the experimental group was greater than that in the control group after treatment (P <0.05). Conclusion Naoxintong capsules combined with atorvastatin in patients with cerebral infarction better efficacy and improve blood lipid levels in patients with long-term clinical application.